Current filters:

Clear current filters  or Add more filters

View Option

Results 1-10 of 16 (Search time: 0.006 seconds).

  Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets (Journal article)

  Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative study (Journal article)

  Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60) (Journal article)

  Integrin Cytoplasmic Tail Derived Peptide Conjugated To A Cell Penetrating Sequential Carrier Inhibits Human Platelet Aggregation (Journal article)

  Amphipathic alpha-helical peptide models of apolipoprotein A-I inhibit LDL oxidation and inactivation of PAF-acetyl-hydrolase in vitro (Journal article)

  Mapping the binding domains of the alpha(IIb) subunit - A study performed on the activated form of the platelet integrin alpha(IIb)beta(3) (Journal article)

  A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin IIb cytoplasmic domain, inhibits platelet activation (Journal article)

  Cargo Delivery into Human Platelets Using the Tat(48-60) Cell-Penetrating Peptide (Journal article)

  Conformational study of new amphipathic alpha-helical peptide models of apoA-I as potential atheroprotective agents (Journal article)

  Synthetic peptide-analogues of the GPIIb subunit inhibit fibrinogen binding to the GPIIb/IIIa receptor and platelet activation (Journal article)